Beacon Hospital

Petaling Jaya 46050

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Head and Neck Squamous Cell Carcinoma (HNSCC), Relapsed or Refractory Multiple Myeloma (RRMM)

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies — Stopped early
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling